Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most transcluded pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Template:DocumentBox (used on 1,354 pages)
  2. Template:DocumentData (used on 1,352 pages)
  3. Template:ReferenceData (used on 1,181 pages)
  4. Document:ICH ICH E6 Guideline R3 (2025) (used on 117 pages)
  5. Document:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 (used on 82 pages)
  6. Document:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 (used on 81 pages)
  7. Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 (used on 64 pages)
  8. Document:USA 21 CFR Part 312 09-Apr-2025 (used on 61 pages)
  9. Document:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 (used on 61 pages)
  10. Document:USA 21 CFR Part 812 09-Apr-2025 (used on 58 pages)
  11. Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 (used on 54 pages)
  12. Document:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 (used on 52 pages)
  13. Document:DEU AMG - Arzneimittelgesetz 19-Jul-2023 (used on 46 pages)
  14. Document:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 (used on 42 pages)
  15. Document:USA 21 CFR Part 50 09-Apr-2025 (used on 28 pages)
  16. Document:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 (used on 21 pages)
  17. Document:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 (used on 18 pages)
  18. Document:USA 45 CFR Part 46 09-Apr-2025 (used on 15 pages)
  19. Document:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 (used on 15 pages)
  20. Document:USA 21 CFR Part 56 09-Apr-2025 (used on 14 pages)
  21. Document:GBR Directive 2001/20/EC 04-Apr-2001 (used on 13 pages)
  22. Document:WMA Declaration of Helsinki 2024 (used on 13 pages)
  23. Document:GBR Directive 93/42/EEC 11-Oct-2007 (used on 10 pages)
  24. Document:WHO WHO - Guidance for best practices for clinical trials 2024 (used on 10 pages)
  25. Document:ICH ICH E8 Guideline R1 (2021) (used on 10 pages)
  26. Document:USA 42 CFR Part 11 09-Apr-2025 (used on 9 pages)
  27. Document:USA 21 CFR Part 11 09-Apr-2025 (used on 9 pages)
  28. Document:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 (used on 9 pages)
  29. Document:EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 (used on 9 pages)
  30. Document:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 (used on 8 pages)
  31. Document:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 (used on 8 pages)
  32. Document:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 (used on 7 pages)
  33. Document:ICH ICH E2A Guideline 1994 (used on 7 pages)
  34. Document:ICH ICH E9 Guideline 1998 (used on 7 pages)
  35. Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 (used on 6 pages)
  36. Document:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 (used on 6 pages)
  37. Document:FRA Constitution du 4 octobre 1958 10-Mar-2024 (used on 6 pages)
  38. Document:ICH ICH E6 Guideline - Annex 2 R3 Annex 2 (used on 6 pages)
  39. Document:USA Informed Consent - FDA Guidance for IRBs, Clinical Investigators, and Sponsors Aug-2023 (used on 6 pages)
  40. Document:GBR MEDDEV 2.7/3 revision 3 May-2015 (used on 5 pages)
  41. Document:FRA Code de la Santé Publique - Partie Réglementaire - 1ere partie, Livre 1er, Titre II 16-May-2025 (used on 5 pages)
  42. Document:USA 21 CFR Part 54 09-Apr-2025 (used on 5 pages)
  43. Document:USA 45 CFR Part 160 09-Apr-2025 (used on 5 pages)
  44. Document:EU EMA/INS/GCP/856758/ 2018 Guideline on the content, management and archiving of the clinical trial master file (paper and/or electronic) 06-Dec-2018 (used on 5 pages)
  45. Document:GBR The Medical Devices Regulations 2002 11-Feb-2021 (used on 5 pages)
  46. Document:EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 (used on 4 pages)
  47. Document:EU EMA/298712/2022 - Complex clinical trials – Questions and answers 23-May-2022 (used on 4 pages)
  48. Document:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 (used on 4 pages)
  49. Document:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 (used on 4 pages)
  50. Document:EU GVP: Module VIII EMA/813938/2011 Rev. 3 (2017) (used on 4 pages)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)